We report a successful outcome on recurrent hyponatremic seizures, treated with agressive sodium replacement therapy in a 12-year-old girl with sickle cell anemia. The cause of her hyponatremia was probably tubular damage due to vaso-occlusive crisis. We achieved rapid correction in neurologic findings, serum sodium level and urinalysis with sodium replacement and fluid therapy in this patient. We excluded stroke based on the findings in cranial magnetic resonance imaging. We conclude that severe seizures found in sickle cell anemia may result from hyponatremia that can be treated by sodium replacement therapy. (J Pediatr Neurol 2004; 2(4): 231-233).
Introduction
Sickle cell anemia was first described by Herrick in 1910. Sickle hemoglobin (HbS) differs from normal adult hemoglobin by the substitution of glutamic acid for valine at the 6th position of the β chain (1) . The clinical manifestations of sickle cell disease are extremely variable. Some patients are entirely asymptomatic and are detected only during population screening, whereas others are constantly plagued by painful episodes. Most patients fall between these extremes and have relatively long asymptomatic periods punctuated by occassional clinical crises (1, 2) .
Many structural and functional abnormalities of the kidney are observed in patients with sickle cell anemia and related hemoglobinopaties (2) . Patients have impaired urinary concentrating ability, defects in urinary acidification, sodium, potassium excretion and other proximal tubular functions (2, 3) . These abnormalities are observed along the entire length of the nephron from the glomerulus to papillary tip, because the rate of oxygen consumption by the kidney is very high. The kidney is especially sensitive to the vaso-occlusion-induced hypoxia that can result from red cell sickling and/or from sickle cell-endotelial cell adhesion. Hyposthenuria is the most frequent renal abnormality in patients with sickle cell anemia (2) (3) (4) (5) .
Acute vaso-occlusion in the brain can result in a devastating, often fatal, cerebrovascular accident, which occurs in approximately 7% of children with sickle cell disease. Hemiplegia, seizures, coma, speech defects, and visial disturbances are the most common signs (1). We report a successful therapy in a case of recurrent seizures due to hyponatremia in a 12-year-old girl with sickle cell anemia, who presented with vaso-occlusive crisis and treated with agressive electrolyte therapy.
Case Report
A 12-year-old girl previously followed-up due to sickle cell anemia since 14-month-old, had painful crisis once a month and frequent pneumonia. She was admitted to our hospital with the complaint of sudden pain of the arms, legs and spine that did not respond to nonsteroidal antiinflammatory drugs. She was diagnosed as having acute painful vasoocclusive crisis. We found her body weight was 35 kg (between 50-75th percentile), her scleras to be subicteric, her legs, arms, and spine were painful in our examination. Other system findings were normal. Complete blood count at admission revealed; hemoglobin 8.8 g/dL, hematocrit 25%, white blood cell count 23,800/mm 3 , platelet count 562,000/mm 3 , peripheral blood smear 56% lymphocytes, 38% polymorphonuclear leucocytes, 6% mononuclear cells, target cells, poikilocytes and sickled cells. Erythrocyte sedimentation rate was 10 mm/h, C-reactive protein was 0.2 mg/dl (Normal: <0.08). Biochemical analysis showed that blood urea nitrogen level 18 mg/dL, creatinine 0.4 mg/dL, potassium 4.1 mmol/L, sodium 135 mmol/L, lactate dehydrogenase 932 U/L, total biliruibin 7.0 mg/dL, indirect bilirubine 6.5 mg/dL. Her urinary specific gravity was 1.012. She was given intravenous fluid 2400 cc/m 2 /day with maintanence sodium (30 mEq/ L), potassium (20 mEq/L), and with morphine to manage her pain.
She had recurrent generalized tonic-clonic seizures for 8 hours from beginning of fluid and morphine (0.05 mg/kg/hr) treatment. Her first seizure responsed to intravenous diazepam (0.5 mg/kg). During the post-ictal period, the patient was unconscious, had no response to pain, her pupils were isocoric and reactive to bright light. Fundoscopic examination revealed no papilledema Babinski reflex was bilaterally positive. The patient had three consecutive seizures an hour, that were controlled with phenytoin (20 mg/kg) and diazepam. Her serum sodium level was very low (115 mmol/L), potassium (4.1 mmol/L), blood urea nitrogen (18 mg/dL), creatinine (0.4 mg/dL), glucose (94 mg/dl), calcium (9.7 mg/dL), and magnesium (2.3 mg/dL) levels were normal. She had poliuria (urine output was 9 ml/kg/hr), urinary specific gravity was 1.002, glucose (+), blood (+), 10-12 erythrocytes/hpf were noticed at her urinary microscopic examination, urine sodium 138 mmol/L, urine β 2 -microglobulin 14 mg/L (Normal: 1.2-2.5 mg/L), and fractional excretion of sodium (FNa) >2.5%. Her arterial blood gas parameters were normal. We could not obtain a cranial magnetic resonance imaging (MRI) because of recurrent generalized tonic-clonic seizures. Her cranial compoterized tomography (CT), revealed normal ventricles, and minimally indistinct cerebral sulci and fissures. Renal ultrasonography was normal and her electroencephalogram was normal.
Intravenous sodium replacement therapy with 3% NaCl was started for severe hyponatremia as 5 mL/kg/hr for one hour. After replacement therapy with 3% NaCl, we continued maintanance and replacement sodium therapy as increased her serum sodium 10 mEq/L throughout day one. The patient's seizures were controlled five hours after sodium replacement therapy, her seizures did not re-appear and her serum sodium was 123 mmol/ L. We considered the patient as having tubular damage of kidneys. We performed a double volume exchange in 24 hours. At the end of the first day of treatment she gave response to verbal and painful stimuli. Her HbS was 23.4%, serum sodium 131 mmol/L, urinary specific gravity 1.002. On day 3 of admission, she could perform her daily activities and complete blood count, serum electrolytes, and urinary analysis was normal, but her poliuria (5 ml/ kg/hr) and hypostenuria were persisted.
The patient's cranial MRI, which was taken on the 10th day of her last seizure, revealed hyperintense signal focusses in subcortical white mater and centrum semiovale at left frontal region (Figure 1 ). These changes were considered to be due to ischemia. In comparison to her previous control cranial MRI examined 35 days before this event, no difference was found. We concluded that the patient did not have a new stroke, and her seizures were due to hyponatremia, resulted from renal tubular damage secondary to vaso-occlusive crisis. Her serum sodium, potassium, urinary specific gravity, urine β 2 -microglobulin and FNa were normal when she was discharged from hospital after 30 days.
Discussion
Sickle cell nephropathy is indicated by sickled erythrocytes, with the consequent effects of decreased medullary blood flow, ischemia, microinfarct, and papillary necrosis (3-7). Impaired urinary concentration ability, renal acidification, hematuria, sodium and potassium secretion can be seen. Although there are many studies showing that proteinuria, nephrotic syndrome, chronic progressive renal failure, and acute renal failure are the outcome of this disease, the pathogenetic mechanism and potential therapies remain to be elucidated (3, 4, 8, 9) . Our patient's hyponatremia, polyuria, hematuria, Figure 1 . T2-weighted MRI shows hyperintense signal in subcortical white mater and centrum semiovale in the left frontal area due to previous stroke attacks.
proteinuria and concentration defect was due to HbS nephropathy. We ruled out inappropriate antidiuretic hormone secretion (SIADH) as urine output was 9 ml/kg/hr. Severe seizures in this patient were due to hyponatremia and did not respond to conventional status epilepticus therapy. We considered only renal tubular damage in our patient because there was no papillary necrosis demonstrated by renal ultrasonography.
Central nervous system (CNS) vaso-occlusive crisis may be seen in sickle cell patients. When the brain is influenced in these patients hemiplegia, seizures, coma, speech defects, and visual disturbances may occur. The abnormal neurologic signs may resolve entirely, improve slightly, or remain constant. Over 70 percent of patients had permanent motor disabilities and deficits in intelligence quotient. Angiographic and postmortem examinations usually reveal multiple stenoses of brain vessels. MRI is positive in approximately 90% of patients with stroke (6, (10) (11) (12) . In our patient we considered stroke as the reason of seizure. We performed her cranial MRI at day 10, there were ischemic areas without any change when compared with her MRI which was done 35 days prior to her crisis, so we ruled out the diagnosis of a new stroke attack.
Inadequate treatment of severe hyponatremia can be cause of severe neurological damage in patients with sickle cell anemia. Severe neurologic symptoms such as conscious changes, seizures and coma usually occur at sodium below 120 mmol/L. Patients should be treated with 3% NaCl urgently when patients have severe neurologic symptoms (9, 13) . Our patient's sodium level was lower than 120 mmol/L, and she had severe and prolonged seizures. First of all, we treated her with 3% NaCl, later we administrated maintanance and replacement sodium therapy. Afterwards, neurologic damage was not apparent in our patient during the hyponatremia treatment.
In conclusion, intractable seizures in patients with sickle cell anemia can mimic changes seen in stroke, SIADH or hyponatremia. Hyponatremia may result from renal tubular damage or SIADH, and should be treated vigorously in HbS patients.
